SEC Form D private-offering filing
Cirius Therapeutics, Inc.
A new SEC Form D private-offering notice from Grand Rapids, MI, a $1,200,000 filer-stated offering target in Biotech. The source filing is one click away.
Cirius Therapeutics, Inc. Verified via SEC Form D
Clinical-stage pharmaceutical company developing oral insulin-sensitizer therapies (lead candidate azemiglitazone/MSDC-0602K, a mitochondrial pyruvate carrier modulator) for metabolic diseases including type 2 diabetes, obesity, and NASH.
Filed 2025-10-08Filed to raise $1,200,000First money in 2025-10-07Raised so far $800,000HQ (as filed) Grand Rapids, MISector Biotech ✓Stage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.